TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PE Bioprocess Consulting AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
348
|
283
|
228 |
| Financial expenses |
112
|
0
|
15 |
| Earnings before taxes |
-86
|
12
|
222 |
| EBITDA |
22
|
4
|
-49 |
| Total assets |
495
|
595
|
694 |
| Current assets |
369
|
356
|
455 |
| Current liabilities |
93
|
57
|
68 |
| Equity capital |
402
|
538
|
626 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.2%
|
90.4%
|
90.2% |
| Turnover per employee |
348
|
283
|
228 |
| Profit as a percentage of turnover |
-24.7%
|
4.2%
|
97.4% |
| Return on assets (ROA) |
5.3%
|
2.0%
|
34.1% |
| Current ratio |
396.8%
|
624.6%
|
669.1% |
| Return on equity (ROE) |
-21.4%
|
2.2%
|
35.5% |
| Change turnover |
65
|
55
|
-178 |
| Change turnover % |
23%
|
24%
|
-44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.